Ask AI
ProCE Banner Activity

Clinical Landscape of TROP-2–Targeted Therapy in Advanced/Metastatic NSCLC

Slideset

Review data on the role of TROP-2–targeted antibody–drug conjugates in the treatment of metastatic NSCLC. 

Released: June 21, 2024

Expiration: June 20, 2025

Review Activity

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.